Omar H. Khalil is a Managing Director at Santé Ventures where he invests in early-stage, Seed and Series A companies across Biotechnology, Healthcare, Therapeutics, Immunology, Inflammation, Oncology, Cardiorenal and Neuropsych. He primarily invests in the United States. He serves on the boards of MycRx, Kestrel Therapeutics, Solu Therapeutics and Geneos Therapeutics, and is a Board Observer at Sensorium Therapeutics. He has invested in companies including MycRx, Kestrel Therapeutics, Sensorium Therapeutics, Solu Therapeutics and Geneos Therapeutics. Previously, he held roles including Partner and Principal at Santé Ventures; Vice President & General Manager at kaleo; Vice President, US Hospital Products at Baxter International Inc.; Senior Director, Program Management (Baxalta) and Director of Strategy & Business Development at Baxter Healthcare Corporation; and Business Analyst at McKinsey & Co. Omar graduated from the University of Michigan College of Engineering and the University of Michigan Rackham Graduate School, and lives in Boston, Massachusetts, United States.
Omar H. Khalil, Managing Director @ Santé. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Omar H. Khalil from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Omar
Map your path to Omar instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Omar
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.